USD 105.86
(-2.04%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.38 Billion USD | 11.08% |
2022 | 2.14 Billion USD | -0.04% |
2021 | 2.14 Billion USD | -12.35% |
2020 | 2.45 Billion USD | 2.75% |
2019 | 2.38 Billion USD | 5.69% |
2018 | 2.25 Billion USD | 8.39% |
2017 | 2.08 Billion USD | 5.71% |
2016 | 1.96 Billion USD | -14.62% |
2015 | 2.3 Billion USD | 97.31% |
2014 | 1.16 Billion USD | 8.79% |
2013 | 1.07 Billion USD | 7.96% |
2012 | 995.3 Million USD | 7.04% |
2011 | 929.8 Million USD | -0.59% |
2010 | 935.3 Million USD | 2.42% |
2009 | 913.2 Million USD | -1.63% |
2008 | 928.3 Million USD | 27.55% |
2007 | 727.8 Million USD | 14.02% |
2006 | 638.3 Million USD | 9.35% |
2005 | 583.7 Million USD | 8.9% |
2004 | 536 Million USD | 1.57% |
2003 | 527.7 Million USD | 104.85% |
2002 | 257.6 Million USD | 28.8% |
2001 | 200 Million USD | 31.32% |
2000 | 152.3 Million USD | 1.53% |
1999 | 150 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 2.38 Billion USD | 0.13% |
2024 Q3 | 2.36 Billion USD | -0.05% |
2024 Q2 | 2.36 Billion USD | -0.77% |
2023 FY | 2.38 Billion USD | 11.08% |
2023 Q1 | 2.24 Billion USD | 4.38% |
2023 Q2 | 2.27 Billion USD | 1.54% |
2023 Q3 | 2.32 Billion USD | 2.09% |
2023 Q4 | 2.38 Billion USD | 2.66% |
2022 Q4 | 2.14 Billion USD | 0.87% |
2022 Q1 | 2.13 Billion USD | -0.74% |
2022 Q2 | 2.12 Billion USD | -0.44% |
2022 Q3 | 2.12 Billion USD | 0.28% |
2022 FY | 2.14 Billion USD | -0.04% |
2021 Q3 | 2.51 Billion USD | -0.62% |
2021 Q1 | 2.51 Billion USD | 2.49% |
2021 Q2 | 2.53 Billion USD | 0.85% |
2021 FY | 2.14 Billion USD | -12.35% |
2021 Q4 | 2.14 Billion USD | -14.67% |
2020 Q4 | 2.45 Billion USD | -1.67% |
2020 Q1 | 2.46 Billion USD | 3.28% |
2020 FY | 2.45 Billion USD | 2.75% |
2020 Q2 | 2.49 Billion USD | 1.35% |
2020 Q3 | 2.49 Billion USD | -0.17% |
2019 FY | 2.38 Billion USD | 5.69% |
2019 Q2 | 2.34 Billion USD | 1.48% |
2019 Q3 | 2.36 Billion USD | 0.76% |
2019 Q4 | 2.38 Billion USD | 0.96% |
2019 Q1 | 2.31 Billion USD | 2.38% |
2018 Q3 | 2.21 Billion USD | 2.83% |
2018 Q4 | 2.25 Billion USD | 1.67% |
2018 FY | 2.25 Billion USD | 8.39% |
2018 Q2 | 2.15 Billion USD | 1.53% |
2018 Q1 | 2.12 Billion USD | 2.12% |
2017 Q3 | 2.08 Billion USD | 2.98% |
2017 Q2 | 2.02 Billion USD | 2.37% |
2017 Q1 | 1.97 Billion USD | 0.39% |
2017 FY | 2.08 Billion USD | 5.71% |
2017 Q4 | 2.08 Billion USD | -0.12% |
2016 Q3 | 2.07 Billion USD | 5.5% |
2016 Q1 | 2.08 Billion USD | -7.6% |
2016 Q4 | 1.96 Billion USD | -4.86% |
2016 FY | 1.96 Billion USD | -14.62% |
2016 Q2 | 1.96 Billion USD | -5.8% |
2015 Q3 | 2.35 Billion USD | -3.42% |
2015 Q2 | 2.44 Billion USD | 100.61% |
2015 Q1 | 1.21 Billion USD | 4.11% |
2015 FY | 2.3 Billion USD | 97.31% |
2015 Q4 | 2.25 Billion USD | -4.4% |
2014 Q1 | 1.12 Billion USD | 4.78% |
2014 Q4 | 1.16 Billion USD | -0.72% |
2014 Q2 | 1.14 Billion USD | 1.89% |
2014 FY | 1.16 Billion USD | 8.79% |
2014 Q3 | 1.17 Billion USD | 2.64% |
2013 Q1 | 1.03 Billion USD | 4.4% |
2013 FY | 1.07 Billion USD | 7.96% |
2013 Q4 | 1.07 Billion USD | -0.68% |
2013 Q3 | 1.08 Billion USD | 2.75% |
2013 Q2 | 1.05 Billion USD | 1.33% |
2012 Q2 | 956 Million USD | 2.03% |
2012 Q1 | 937 Million USD | 0.77% |
2012 FY | 995.3 Million USD | 7.04% |
2012 Q4 | 995.3 Million USD | 0.12% |
2012 Q3 | 994.1 Million USD | 3.99% |
2011 Q2 | 975.1 Million USD | 1.74% |
2011 Q3 | 968.4 Million USD | -0.69% |
2011 Q4 | 929.8 Million USD | -3.99% |
2011 FY | 929.8 Million USD | -0.59% |
2011 Q1 | 958.4 Million USD | 2.35% |
2010 Q4 | 936.4 Million USD | 1.19% |
2010 Q2 | 885.8 Million USD | -1.19% |
2010 FY | 935.3 Million USD | 2.42% |
2010 Q1 | 896.5 Million USD | -1.83% |
2010 Q3 | 925.4 Million USD | 4.47% |
2009 FY | 913.2 Million USD | -1.63% |
2009 Q4 | 913.2 Million USD | -6.06% |
2009 Q3 | 972.1 Million USD | -0.9% |
2009 Q2 | 980.9 Million USD | 3.58% |
2009 Q1 | 947 Million USD | 2.01% |
2008 FY | 928.3 Million USD | 27.55% |
2008 Q1 | 756.6 Million USD | 3.96% |
2008 Q2 | 800.7 Million USD | 5.83% |
2008 Q3 | 843 Million USD | 5.28% |
2008 Q4 | 928.3 Million USD | 10.12% |
2007 Q1 | 658.8 Million USD | 3.21% |
2007 Q4 | 727.8 Million USD | -0.6% |
2007 Q3 | 732.2 Million USD | 7.22% |
2007 Q2 | 682.9 Million USD | 3.66% |
2007 FY | 727.8 Million USD | 14.02% |
2006 FY | 638.3 Million USD | 9.35% |
2006 Q1 | 599.5 Million USD | 2.71% |
2006 Q2 | 606.1 Million USD | 1.1% |
2006 Q3 | 630.9 Million USD | 4.09% |
2006 Q4 | 638.3 Million USD | 1.17% |
2005 Q1 | 551.9 Million USD | 2.97% |
2005 FY | 583.7 Million USD | 8.9% |
2005 Q2 | 568 Million USD | 2.92% |
2005 Q3 | 586.6 Million USD | 3.27% |
2005 Q4 | 583.7 Million USD | -0.49% |
2004 Q1 | 503.8 Million USD | -4.53% |
2004 Q4 | 536 Million USD | 5.85% |
2004 Q3 | 506.4 Million USD | 0.48% |
2004 Q2 | 504 Million USD | 0.04% |
2004 FY | 536 Million USD | 1.57% |
2003 FY | 527.7 Million USD | 104.85% |
2003 Q1 | 265.9 Million USD | 3.22% |
2003 Q2 | 280.8 Million USD | 5.6% |
2003 Q3 | 294 Million USD | 4.7% |
2003 Q4 | 527.7 Million USD | 79.49% |
2002 Q3 | 253.2 Million USD | 5.02% |
2002 Q1 | 219.8 Million USD | 9.9% |
2002 Q2 | 241.1 Million USD | 9.69% |
2002 FY | 257.6 Million USD | 28.8% |
2002 Q4 | 257.6 Million USD | 1.74% |
2001 Q3 | 187.6 Million USD | 11.2% |
2001 Q2 | 168.7 Million USD | 5.44% |
2001 FY | 200 Million USD | 31.32% |
2001 Q1 | 160 Million USD | 5.26% |
2001 Q4 | 200 Million USD | 6.61% |
2000 Q4 | 152 Million USD | 0.0% |
2000 FY | 152.3 Million USD | 1.53% |
1999 FY | 150 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Abbott Laboratories | 6.57 Billion USD | 63.696% |
Allurion Technologies Inc. | 6.17 Million USD | -38551.758% |
Artivion, Inc. | 81.97 Million USD | -2809.632% |
Avanos Medical, Inc. | 163.2 Million USD | -1361.52% |
Butterfly Network, Inc. | 75.83 Million USD | -3045.167% |
Butterfly Network, Inc. | 75.83 Million USD | -3045.167% |
Bio-Rad Laboratories, Inc. | 780.51 Million USD | -205.592% |
Boston Scientific Corporation | 2.48 Billion USD | 3.977% |
Perspective Therapeutics, Inc. | 1.4 Million USD | -169183.18% |
CONMED Corporation | 318.32 Million USD | -649.299% |
Edwards Lifesciences Corporation | 1.16 Billion USD | -104.177% |
Paragon 28, Inc. | 98.06 Million USD | -2332.339% |
Glaukos Corporation | 41.98 Million USD | -5580.941% |
Globus Medical, Inc. | 848.13 Million USD | -181.229% |
Inspire Medical Systems, Inc. | 33.88 Million USD | -6939.103% |
Integer Holdings Corporation | 239.71 Million USD | -895.011% |
Medtronic plc | 5.21 Billion USD | 54.28% |
Nevro Corp. | 118.67 Million USD | -1909.842% |
Owlet, Inc. | 6.49 Million USD | -36634.945% |
Penumbra, Inc. | 388.02 Million USD | -514.706% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 2.39 Billion USD | 0.409% |
Sonendo, Inc. | 11.07 Million USD | -21438.739% |
STERIS plc | 674.53 Million USD | -253.607% |
Stryker Corporation | 4.84 Billion USD | 50.75% |
Vapotherm, Inc. | 22.96 Million USD | -10284.883% |